trans-Pralsetinib - ≥96% , Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor, CAS No.2097132-93-7, Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor

CAS: 2097132-93-7 Cat. No.: T651511 Peso molecular: 533.60 Número EC: 861-037-3 PubChem CID: 129073603
Disponible para pedir
GRADE & PURITY ≥96%
Synonyms
:PRALSETINIB [ORANGE BOOK] | BLU123244 | BLU-123244 | X581238 | X-581238 | WHO 11004 | BDBM435010 | Pralsetinib [USAN] | SCHEMBL18789228 | cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methy
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
5mg
T651511-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
260,90US$
10mg
T651511-10mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
370,90US$
50mg
T651511-50mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
1.370,90US$
100mg
T651511-100mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
2.160,90US$
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥96% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Descripción general

trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129

Form:Solid

IC50& Target:RET

Specifications

Sinónimos
:PRALSETINIB [ORANGE BOOK] | BLU123244 | BLU-123244 | X581238 | X-581238 | WHO 11004 | BDBM435010 | Pralsetinib [USAN] | SCHEMBL18789228 | cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methy
Especificaciones y pureza
≥96%
Mecanismos bioquímicos y fisiológicos
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129.
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Tipo de acción
INHIBITOR
Mecanismo de acción
Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor
Pureza
≥96%
Propiedades del producto
ALogP3.1
Nombres e identificadores
Sonrisas canónicasCC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC
IUPAC NameN-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
InChIKeyGBLBJPZSROAGMF-SIYOEGHHSA-N
INCHI1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1
Isómeros SMILES CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC
CAS alternativo 2097132-94-8
PubChem CID 129073603
Términos de entrada MeSH BLU-667;Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-;gavreto;pralsetinib;trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethy
Peso molecular 533.60

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasePyridines and derivatives
SubclassPyrazolylpyridines
Intermediate Tree Nodes Not available
Direct ParentPyrazolylpyridines
Alternative Parents Aminopyrimidines and derivatives  Imidolactams  Aryl fluorides  Pyrazoles  Heteroaromatic compounds  Secondary carboxylic acid amides  Amino acids and derivatives  Secondary amines  Dialkyl ethers  Azacyclic compounds  Organopnictogen compounds  Organofluorides  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents 2-pyrazolylpyridine - Aminopyrimidine - Imidolactam - Pyrimidine - Aryl halide - Aryl fluoride - Heteroaromatic compound - Pyrazole - Azole - Secondary carboxylic acid amide - Carboxamide group - Amino acid or derivatives - Azacycle - Secondary amine - Ether - Dialkyl ether - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Carbonyl group - Amine - Aromatic heteromonocyclic compound
DescripciónThis compound belongs to the class of organic compounds known as pyrazolylpyridines. These are compounds containing a pyrazolylpyridine skeleton, which consists of a pyrazole linked (not fused) to a pyridine by a bond.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
RET Tclin Proto-oncogene tyrosine-protein kinase receptor Ret (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KDR Tclin Vascular endothelial growth factor receptor 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
SolubilidadDMSO : 100 mg/mL (187.41 mM; Need ultrasonic)
Peso molecular533.600 g/mol
XLogP33.100
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Exact Mass533.266 Da
Monoisotopic Mass533.266 Da
Topological Polar Surface Area136.000 Ų
Heavy Atom Count39
Formal Charge0
Complexity816.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.